AstraZeneca wants Serum Institute of India listed as manufacturing site“We have requested the addition of Serum Institute of India as an alternative manufacturing site on the Vaxzevria licence,” an AstraZeneca ...
SGX Nifty down 100 points; here's what changed for market while you were sleepingAsian shares edged lower on Tuesday amid uncertainty about Senate runoffs in Georgia, which could have a big impact on incoming US Presiden...
Approval based on adequate safety data: Bharat BiotechBharat Biotech CEO Krishna Ella said he doesn’t know what the regulator meant when it accorded “emergency use permission under clinical tri...
Participant in Serum Institute's Covid vaccine trial seeks Rs 5 crore compensationThe legal notice to SII says the participant suffered a serious adverse event after being administered the under-trial vaccine, and is dema...
Rs 2.23 lakh crore wiped off! Sensex crashes 634 points on global selloff; Nifty ends at 11,334The tech-heavy Nasdaq plunged 5 per cent overnight and the S&P 500 dropped 3.5 per cent. Those were the steepest Wall Street losses since J...
AstraZeneca to receive over Rs 140 crore grant from promoterAstraZeneca Pharma AB would be provide the first tranche of Rs 74 cr to the Indian firm in the current financial year, it added.
- India's first patent tech auction in Ahmedabad this week
A herbal drink that tastes like beer, a bio-insecticide product that attracts and kills mosquitoes using bird feather constitute a few samp...
- Ranbaxy, Daiichi say deal's on track
Pharma analysts are apprehensive that the investigations against Ranbaxy might impact its product flow to US and its out-of-court settlemen...